Revenue: The sum of all revenue fields included for a company's operating activities.
Seres Therapeutics, Inc. (MCRB) had Revenue of $0.06M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$0.06M |
$-41.25M |
|
-- |
|
$0.06M |
|
$39.59M |
|
$-39.53M |
|
$-1.72M |
|
$-41.25M |
|
$-41.25M |
|
$-41.25M |
|
$-41.25M |
|
$-41.25M |
|
$-41.25M |
|
$-39.53M |
|
$-37.48M |
|
128.00M |
|
128.00M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$175.41M |
|
$22.46M |
|
$183.19M |
|
$358.60M |
|
$98.66M |
|
$101.54M |
|
$304.80M |
|
$403.46M |
|
$-44.86M |
|
$-44.86M |
|
$-44.86M |
|
135.04M |
|
| Cash Flow Statement Financials | |
$-117.35M |
|
$10.58M |
|
$71.70M |
|
$171.22M |
|
$136.15M |
|
$-35.07M |
|
$34.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.78 |
|
-- |
|
-- |
|
1.79 |
|
-2.26 |
|
100.00% |
|
-61759.51% |
|
-61759.52% |
|
-- |
|
-64450.16% |
|
-64450.16% |
|
$-125.33M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
0.01M |
|
91.96% |
|
91.96% |
|
-11.50% |
|
-72.76% |
|
$-0.33 |
|
$-0.98 |
|
$-0.92 |
|